SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,599.91 -585.67
( -0.72%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

43,604.51 -547.48
(-1.24%)

Dow Jones

6,258.79 -101.60
(1.60%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,068.58 -64.23
(-0.70%)

Forex

USD-INR

87.57 0.14
(0.16%)

EUR-INR

100.09 -0.48
(-0.48%)

GBP-INR

115.87 -0.55
(-0.47%)

JPY-INR

0.58 0.00
(-0.74%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

592.092596

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

29.92

32608.59

EPS(TTM)

Face Value()

Div & Yield %

66.14

0.91

Back

aditya birla real estate ltd

Texel Industries Ltd - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March 2025

May 29,2025

Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2025.

24,565.35 -203.00 (-0.82%)

80,599.91 -585.67 ( -0.72%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

43,604.51 -547.48 (-1.24%)

6,258.79 -101.60 (1.60%)

40,837.80 -232.02 (-0.56%)

9,068.58 -64.23 (-0.70%)

87.57 0.14 (0.16%)

100.09 -0.48 (-0.48%)

115.87 -0.55 (-0.47%)

0.58 0.00 (-0.74%)